Posts in category Economic Times
Kotak Bank falls another 3% as Manian exit adds to talent loss (03-05-2024)
Kotak Bank shares fell as much as 4.4% during Thursday's trading to ₹1,552.4 before recovering partially. On the BSE alone, over 1.05 crore Kotak shares changed hands against a two-week daily average of 5.87 lakh shares.
Gift Nifty down 2 points; here’s the trading setup for today’s session (03-05-2024)
Domestic markets rose after US Fed's rate decision. Nifty futures flat. India VIX up. Asia equities, yen advance pre US jobs data. US stocks gain. Oil prices edge up on OPEC+ cuts, amid Israel-Hamas war.
Stocks in news: Coal India, YES Bank, Coforge, Tata Technologies, Bajaj Finance, Adani Green (03-05-2024)
Markets rebounded on Thursday. Coal India reports 26% net profit growth. YES Bank may see Carlyle Group stake sale. Coforge approves Cigniti Technologies acquisition. Titan, Adani Green, Britannia, MRF, Tata Tech, Godrej Properties in focus ahead of earnings.
Gilty, My Lord! Pension funds bond more with govt debt (03-05-2024)
NPS drives record investment in government bonds to 4.4%, totaling ₹4.67 lakh crore. Shift towards debt, influenced by market performance, particularly in fixed-income, reflects security-focused investment decisions amidst changing yield dynamics and retirement strategies.
Fizz on the Street: Coke bottler looks to uncork IPO plans (03-05-2024)
Coca-Cola's bottling operations in India are handled by HCCB and half a dozen franchisees that manufacture and distribute fizzy drinks Coke, Thums Up and Sprite, juices Minute Maid and Maaza, and Kinley water. Bottling is split evenly between HCCB and the franchisees.
Apple unveils record $110 billion buyback as results beat low expectations (03-05-2024)
Apple's quarterly results beat expectations with a record share buyback program and increased cash dividend. The $110 billion stock buyback is the largest in the company's history. CEO Tim Cook foresees revenue growth.
Ajanta Pharma Q4 Results: Net profit soars 66% YoY to Rs 203 cr (02-05-2024)
Revenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta Pharma said in a regulatory filing. For the year ended March 31, 2024, the company posted a consolidated net profit of Rs 816 crore as against Rs 588 crore in the 2022-23 fiscal year.
Coforge Q4 Results: Net profit zooms 95% YoY to Rs 223.7 crore (02-05-2024)
Coforge's revenue from operations was up 8.68 per cent to Rs 2,358.5 crore against Rs 2,170 crore in the corresponding quarter in FY23, according to a regulatory filing by the company.
RailTel Q4 Results: Net profit rises 3% YoY to Rs 77.5 crore, total income at Rs 852 cr (02-05-2024)
The Mini Ratna company under the Railway Ministry reported a total income of Rs 852 crore for the last quarter of 2023-24 against Rs 707.29 crore in the year-ago period, according to an exchange filing.
Ceat Q4 Results: Net profit dips 23% YoY to Rs 102 crore (02-05-2024)
Its revenue from operations rose to Rs 2,992 crore in the period under review from Rs 2,875 crore in the fourth quarter of FY23. For the fiscal ended March 2024, the company posted a net profit of Rs 635 crore compared to Rs 182 crore in 2022-23.